Atypical Atm-p53 genetic interaction in osteogenesis is mediated by Smad1 signaling

Journal of Molecular Cell Biology

Volumn 4, Issue 2, 2012, Pages 118-120

  Ma, Gang ^a   Li, Lili ^b   Hu, Yuanyu ^c   Chau, Jenny Fung Ling ^c   Au, Bi Jin ^c   Jia, Deyong ^a   Liu, Huijuan ^a   Yeh, James ^a   He, Lin ^a   Hao, Aijun ^b   Li, Baojie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ATM PROTEIN; BONE MORPHOGENETIC PROTEIN 2; PROTEIN P21; PROTEIN P53; SMAD1 PROTEIN; SMAD5 PROTEIN; TRANSCRIPTION FACTOR RUNX2;

BINDING SITE; BONE DEVELOPMENT; BONE MINERALIZATION; CARCINOGENESIS; CELL CYCLE ARREST; CELL DIFFERENTIATION; DOWN REGULATION; GENE DELETION; GENE INTERACTION; HOMEOSTASIS; LETTER; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETROVIRUS; SIGNAL TRANSDUCTION; SURVIVAL; UPREGULATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84860145342     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjs006     Document Type: Letter

References (10)

1. Barlow, C., Brown, K.D., Deng, C.X., et al. (1997). Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways. Nat. Genet. 17, 453-456.
2. Ho, J., and Benchimol, S. (2003). Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ. 10, 404-408.
3. Li, B. (2008). Bone morphogenetic protein-Smad pathway as drug targets for osteoporosis and cancer therapy. Endocr. Metab. Immune Disord. Drug Targets 8, 208-219.
4. Liu, B., Chen, Y., and St. Clair, D.K. (2008). ROS and p53: a versatile partnership. Free Radic. Biol. Med. 44, 1529-1535.
5. Rasheed, N., Wang, X., Niu, Q.T., et al. (2006). Atmdeficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis. Hum. Mol. Genet. 15, 1938-1948.
6. Sherr, C.J. (1998). Tumor surveillance via the ARFp53 pathway. Genes Dev. 12, 2984-2991.
7. Stiewe, T. (2007). The p53 family in differentiation and tumorigenesis. Nat. Rev. Cancer 7, 165-168.
8. Wang, X., Kua, H.Y., Hu, Y., et al. (2006). p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J. Cell Biol. 172, 115-125.
9. Wang, X., Goh, C.H., and Li, B. (2007). p38 mitogenactivated protein kinase regulates osteoblast differentiation through osterix. Endocrinology 148, 1629-1637.
10. Xu, Y., Yang, E.M., Brugarolas, J., et al. (1998). Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm2/2 mice. Mol. Cell. Biol. 18, 4385-4390.